← All trials
NCT06373042
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2024
- Primary completion
- Jul 31, 2026
- Completion date
- Oct 31, 2026
- First posted
- Apr 18, 2024
- Last posted
- May 16, 2024
- Enrollment
- 712
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- People's Liberation Army of ChinaLead sponsor
- Mianyang Central HospitalCollaborator
- Government of ChinaOfficial
- People's Liberation Army of ChinaSponsor investigator
- Chongqing Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.